From the Division of Cardiology, Department of Medicine, National
Yang-Ming University School of Medicine (S.-H.L.), and Veterans General
Hospital-Taipei, Taipei, Taiwan.
Correspondence to Shih-Ann Chen, MD, Division of Cardiology, Veterans General Hospital-Taipei, 201 Sec 2, Shih-Pai Rd, Taipei, Taiwan. E-mail sachen{at}vghtpe.gov.tw
Background—Atrial fibrillation (AF)
has been shown to shorten the atrial effective refractory period (ERP)
and make the atrium more vulnerable to AF. This study investigated the
effect of atrial rate and antiarrhythmic drugs on ERP shortening
induced by tachycardia.
Methods and Results—Seventy adult patients without structural
heart disease were included. For the first part of the study, right
atrial ERP was measured with a drive cycle length of 500 ms before and
after 10 minutes of rapid atrial pacing using five pacing cycle lengths
(450, 400, 350, 300, and 250 ms) in 10 patients. For the second part of
the study, the remaining 60 patients were included to study the effects
of antiarrhythmic drugs on changes in atrial ERP induced by AF. Atrial
ERP was measured with a drive cycle of 500 ms before and after an
episode of pacing-induced AF. After the patients were randomized to
receive one of six antiarrhythmic drugs (procainamide,
propafenone, propranolol, dl-sotalol,
amiodarone, and verapamil), atrial ERP was measured
before and after another episode of pacing-induced AF. In the first
part of the study, atrial ERP shortened significantly after 10 minutes
of rapid atrial pacing, and the degree of shortening was correlated
with pacing cycle length. The second part of the study showed that
atrial ERP shortened after conversion of AF (172±15 versus 202±14 ms,
P<0.0001) and that ERP shortening was attenuated after
verapamil infusion (-4.6±1.2% versus -15.1±3.4%,
P<0.001) but was unchanged after infusion of the other
antiarrhythmic drugs. Furthermore, all of these antiarrhythmic drugs
could decrease the incidence and duration of secondary AF.
Conclusions—The atrial ERP shortening induced by
tachycardia was a rate-dependent response.
Verapamil, but not other antiarrhythmic drugs, could
markedly attenuate this effect. However, verapamil and the
other drugs could decrease the incidence and duration of secondary AF.
© 1998 American Heart Association, Inc.
Clinical Investigation and Reports
Tachycardia-Induced Change of Atrial Refractory Period in Humans
Rate Dependency and Effects of Antiarrhythmic Drugs
Key Words: antiarrhythmia agents • atrium • fibrillation • electrophysiology
This article has been cited by other articles:
 |
|
 |
|
  G. L. Stump, A. A. Wallace, C. P. Regan, and J. J. Lynch Jr. In Vivo Antiarrhythmic and Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide J. Pharmacol. Exp. Ther., December 1, 2005; 315(3): 1362 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Scherlag, W. Yamanashi, U. Patel, R. Lazzara, and W. M. Jackman Autonomically Induced Conversion of Pulmonary Vein Focal Firing Into Atrial Fibrillation J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1878 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Vest, X. H.T. Wehrens, S. R. Reiken, S. E. Lehnart, D. Dobrev, P. Chandra, P. Danilo, U. Ravens, M. R. Rosen, and A. R. Marks Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation Circulation, April 26, 2005; 111(16): 2025 - 2032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shiroshita-Takeshita, G. Schram, J. Lavoie, and S. Nattel Effect of Simvastatin and Antioxidant Vitamins on Atrial Fibrillation Promotion by Atrial-Tachycardia Remodeling in Dogs Circulation, October 19, 2004; 110(16): 2313 - 2319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-C. Ueng, T.-P. Tsai, W.-C. Yu, C.-F. Tsai, M.-C. Lin, K.-C. Chan, C.-Y. Chen, D.-J. Wu, C.-S. Lin, and S.-A. Chen Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation: Results of a prospective and controlled study Eur. Heart J., December 1, 2003; 24(23): 2090 - 2098. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Valenzuela Pharmacological electrical remodelling in human atria induced by chronic {beta}-blockade Cardiovasc Res, June 1, 2003; 58(3): 498 - 500. [Full Text] [PDF]
|
|
|
|
|
|
K. Shinagawa, A. Shiroshita-Takeshita, G. Schram, and S. Nattel Effects of Antiarrhythmic Drugs on Fibrillation in the Remodeled Atrium: Insights Into the Mechanism of the Superior Efficacy of Amiodarone Circulation, March 18, 2003; 107(10): 1440 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-F. Tse and C.-P. Lau Electrophysiologic actions of dl-sotalolin patients with persistent atrial fibrillation J. Am. Coll. Cardiol., December 18, 2002; 40(12): 2150 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Miyata, D. P. Zipes, S. Hall, and M. Rubart KB-R7943 Prevents Acute, Atrial Fibrillation-Induced Shortening of Atrial Refractoriness in Anesthetized Dogs Circulation, September 10, 2002; 106(11): 1410 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Fan, K. L. Lee, W.-H. Chow, E. Chau, and C.-P. Lau Internal Cardioversion of Chronic Atrial Fibrillation During Percutaneous Mitral Commissurotomy: Insight Into Reversal of Chronic Stretch-Induced Atrial Remodeling Circulation, June 11, 2002; 105(23): 2746 - 2752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F Bosch and S. Nattel Cellular electrophysiology of atrial fibrillation Cardiovasc Res, May 1, 2002; 54(2): 259 - 269. [Full Text] [PDF]
|
|
|
|
|
|
B. J.J.M. Brundel, R. H. Henning, H. H. Kampinga, I. C. Van Gelder, and H. J.G.M. Crijns Molecular mechanisms of remodeling in human atrial fibrillation Cardiovasc Res, May 1, 2002; 54(2): 315 - 324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nattel Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management? Cardiovasc Res, May 1, 2002; 54(2): 347 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Shinagawa, H. Mitamura, S. Ogawa, and S. Nattel Effects of inhibiting Na+/H+-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling Cardiovasc Res, May 1, 2002; 54(2): 438 - 446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Kurita, H. Mitamura, A. Shiroshita-Takeshita, A. Yamane, M. Ieda, O. Kinebuchi, T. Sato, S. Miyoshi, M. Hara, S. Takatsuki, et al. Daily oral verapamil before but not after rapid atrial excitation prevents electrical remodeling Cardiovasc Res, May 1, 2002; 54(2): 447 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ricci, C. Pignalberil, M. Disertori, A. Capucci, L. Padeletti, G. Botto, G. Boriani, F. Miraglia, T. de Santo, and M. Santini Antitachycardia pacing therapy to treat spontaneous atrial tachyarrhythmias: the 7250 dual defibrillator Italian Registry Eur. Heart J. Suppl., November 1, 2001; 3(suppl_P): P25 - P32. [Abstract] [PDF]
|
|
|
|
 |
|
 E. BERTAGLIA, D. D'ESTE, A. ZANOCCO, F. ZERBO, and P. PASCOTTO Effects of pretreatment with verapamil on early recurrences after electrical cardioversion of persistent atrial fibrillation: a randomised study Heart, May 1, 2001; 85(5): 578 - 580. [Full Text]
|
|
|
|
|
|
C Pandozi and M Santini Update on atrial remodelling owing to rate. Does atrial fibrillation always 'beget' atrial fibrillation? Eur. Heart J., April 1, 2001; 22(7): 541 - 553. [PDF]
|
|
|
|
|
|
A. Benardeau, S. Fareh, and S. Nattel Effects of verapamil on atrial fibrillation and its electrophysiological determinants in dogs Cardiovasc Res, April 1, 2001; 50(1): 85 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. J. M. Brundel, I. C. Van Gelder, R. H. Henning, A. E. Tuinenburg, M. Wietses, J. G. Grandjean, A. A. M. Wilde, W. H. Van Gilst, and H. J. G. M. Crijns Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels J. Am. Coll. Cardiol., March 1, 2001; 37(3): 926 - 932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Sun, D. Chartier, N. Leblanc, and S. Nattel Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes Cardiovasc Res, March 1, 2001; 49(4): 751 - 761. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fareh, A. Benardeau, and S. Nattel Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs Cardiovasc Res, March 1, 2001; 49(4): 762 - 770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. J. M. Brundel, I. C. Van Gelder, R. H. Henning, R. G. Tieleman, A. E. Tuinenburg, M. Wietses, J. G. Grandjean, W. H. Van Gilst, and H. J. G. M. Crijns Ion Channel Remodeling Is Related to Intraoperative Atrial Effective Refractory Periods in Patients With Paroxysmal and Persistent Atrial Fibrillation Circulation, February 6, 2001; 103(5): 684 - 690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Allessie, P. A. Boyden, A. J. Camm, A. G. Kleber, M. J. Lab, M. J. Legato, M. R. Rosen, P. J. Schwartz, P. M. Spooner, D. R. Van Wagoner, et al. Pathophysiology and Prevention of Atrial Fibrillation Circulation, February 6, 2001; 103(5): 769 - 777. [Full Text] [PDF]
|
|
|
|
|
|
C. Pandozi, L. Bianconi, L. Calo, A. Castro, F. Lamberti, M. C. Scianaro, G. Gentilucci, and M. Santini Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2234 - 2241. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-J. Chen, S.-A. Chen, M.-S. Chang, and C.-I Lin Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation Cardiovasc Res, November 1, 2000; 48(2): 265 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Sparks, S. Jayaprakash, J. K. Vohra, and J. M. Kalman Electrical Remodeling of the Atria Associated With Paroxysmal and Chronic Atrial Flutter Circulation, October 10, 2000; 102(15): 1807 - 1813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Amar, N. Roistacher, V. W. Rusch, D. H. Y. Leung, I. Ginsburg, H. Zhang, M. S. Bains, R. J. Downey, R. J. Korst, and R. J. Ginsberg Effects of diltiazem prophylaxis on the incidence and clinical outcome of atrial arrhythmias after thoracic surgery J. Thorac. Cardiovasc. Surg., October 1, 2000; 120(4): 790 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Friedman, M. Win, A. Hussain, and A. Sinha Effects of Cardiac Glycosides on Atrial Contractile Dysfunction After Short-term Atrial Fibrillation Chest, October 1, 2000; 118(4): 1116 - 1126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Nattel and D. Li Ionic Remodeling in the Heart : Pathophysiological Significance and New Therapeutic Opportunities for Atrial Fibrillation Circ. Res., September 15, 2000; 87(6): 440 - 447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bollmann Quantification of electrical remodeling in human atrial fibrillation Cardiovasc Res, August 1, 2000; 47(2): 207 - 209. [Full Text] [PDF]
|
|
|
|
|
|
E. G. Manios, E. M. Kanoupakis, G. I. Chlouverakis, M. D. Kaleboubas, H. E. Mavrakis, and P. E. Vardas Changes in atrial electrical properties following cardioversion of chronic atrial fibrillation: relation with recurrence Cardiovasc Res, August 1, 2000; 47(2): 244 - 253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dorian and D. Newman Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview Europace, January 1, 2000; 2(4): 277 - 285. [Abstract] [PDF]
|
|
|
|
|
|
A. A. Grace and A.J. Camm Voltage-gated calcium-channels and antiarrhythmic drug action Cardiovasc Res, January 1, 2000; 45(1): 43 - 51. [Full Text] [PDF]
|
|
|
|
|
|
S. Fareh, A. Benardeau, B. Thibault, and S. Nattel The T-Type Ca2+ Channel Blocker Mibefradil Prevents the Development of a Substrate for Atrial Fibrillation by Tachycardia-Induced Atrial Remodeling in Dogs Circulation, November 23, 1999; 100(21): 2191 - 2197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-A. Chen, M.-H. Hsieh, C.-T. Tai, C.-F. Tsai, V. S. Prakash, W.-C. Yu, T.-L. Hsu, Y.-A. Ding, and M.-S. Chang Initiation of Atrial Fibrillation by Ectopic Beats Originating From the Pulmonary Veins : Electrophysiological Characteristics, Pharmacological Responses, and Effects of Radiofrequency Ablation Circulation, November 2, 1999; 100(18): 1879 - 1886. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. De Simone, G. Stabile, D. F. Vitale, P. Turco, M. Di Stasio, F. Petrazzuoli, M. Gasparini, C. De Matteis, R. Rotunno, and T. Di Napoli Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion J. Am. Coll. Cardiol., September 1, 1999; 34(3): 810 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-M. Rodriguez, C. Timmermans, and H. J. J. Wellens Are Electrophysiological Changes Induced by Longer Lasting Atrial Fibrillation Reversible? : Observations Using the Atrial Defibrillator Circulation, July 13, 1999; 100(2): 113 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nattel Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation Cardiovasc Res, May 1, 1999; 42(2): 298 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-C. Yu, S.-H. Lee, C.-T. Tai, C.-F. Tsai, M.-H. Hsieh, C.-C. Chen, Y.-A. Ding, M.-S. Chang, and S.-A. Chen Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man Cardiovasc Res, May 1, 1999; 42(2): 470 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-H. Lee, F.-Y. Lin, W.-C. Yu, J.-J. Cheng, P. Kuan, C.-R. Hung, M.-S. Chang, and S.-A. Chen Regional Differences in the Recovery Course of Tachycardia-Induced Changes of Atrial Electrophysiological Properties Circulation, March 9, 1999; 99(9): 1255 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Sparks, S. Jayaprakash, H. G. Mond, J. K. Vohra, L. E. Grigg, and J. M. Kalman Left atrial mechanical function after brief duration atrial fibrillation J. Am. Coll. Cardiol., February 1, 1999; 33(2): 342 - 349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Valderrabano and B. N. Singh Review : Electrophysiologic and Antiarrhythmic Effects of Propafenone: Focus on Atrial Fibrillation Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1999; 4(3): 183 - 198. [PDF]
|
|